The uplisting likely to happen before the holidays. Milestones #2, #3 and #4 likely to happen before #1. The next two months are going to be interesting.


Milestone: Nasdaq uplist
Bonus Performance: 30%
Completion Timing: 12/31/14

Milestone: Eltoprazine US IND filed and approved for LID
Bonus Performance: 30%
Completion Timing: 12/31/14

Milestone: LymPro partner validation of analytical performance package (APP) and CLIA certification
Bonus Performance: 25%
Completion Timing: 12/31/14

Milestone: MANF Orphan drug designation applications filed and approved for both Ocular Ischemic Syndrome (OIA) and Retinitis Pigmentosa
Bonus Performance: 15%
Completion Timing: 12/31/14

Read More: http://investorshangout.com/post/view?id=2126...z3FnBILLlE

Read More: http://investorshangout.com/post/view?id=2126...z3FnLLHNRk